Bail, no way. We need to see what's behind that green door - " US FDA Breakthrough Therapy Designation – for a major cardiovascular indication."
Once that goes into action (BOM2) is when we will see an RVX share price appreciation. Once in action, I suspect the SPP could go as high as CAN $5 almost overnight. If the new partner is a major pharma, it could escalate a lot higher. Uplisting of RVX to Nasdaq should be seriously considered by management at that point in time.
Koo
